The FDA warned today that supplies of doxycycline capsules may be in short supply in the U.S. in coming weeks owing to the shutdown of 2 large pharmaceutical manufacturing plants in China.
Stay current on CDC recommendations for COVID-19 with epocrates exclusive decision tool: COVID-19 (2019 Novel Coronavirus).
| Guideline | Resources |
| FDA Announces Doxycycline Shortage Due to COVID-19 Pandemic |
Key Points
|
FDA
Epocrates Guideline Synopsis Last Update:
Mar 17, 2020
Source:
FDA
- FDA